A prophylactic multi-strain probiotic treatment to reduce the absorption of toxic elements. In-vitro study and biomonitoring of breast milk and infant stools
Potential exposure to toxic elements initially occurs during gestation and after birth via breast milk, which is the principal source of nutrients for infants during the first months of life. In this study, we evaluated whether maternal oral supplementation with a multi-strain probiotic product can protect infants from exposure to arsenic (As), cadmium (Cd), mercury (Hg), and lead (Pb) via breast milk.